AKT1 and pulmonary fibrosis: These findings suggest that TET has the potential to suppress silica-induced pulmonary fibrosis by targeting the PI3K/AKT signaling pathway, providing valuable insights into its therapeutic potential for the treatment of pulmonary fibrosis and silicosis.